8th Gene Therapy Development Summit
VGXI is thrilled to be part of the Gene Therapy Development Summit. Bringing together key figures from industry, regulatory bodies, patient non-profits, payers, and key service providers. The Gene Therapy Development Summit is the field’s foremost meeting for collectively progressing rare gene therapy programs into and through the clinic. Join us to leverage essential insights from over 200 peers from leading biopharma companies with direct experience in driving gene therapies through the clinic and into the market.
Meet the VGXI Team
VGXI’s Associate Director of Business Development, Michelle Stretz, is attending and looks forward to discussing our latest technology innovations and plasmid DNA manufacturing solutions to accelerating safe, effective and accessible Gene Therapies in Rare Disease. Complete the form below to schedule a meeting during the 8th Annual Gene Therapy Development Summit to explore how VGXI can support your gene therapy needs. We look forward to seeing you in Boston!
